Show simple item record

dc.contributor.authorFagbami, A H
dc.contributor.authorHalstead, S B
dc.date.accessioned2023-01-13T20:22:12Z
dc.date.available2023-01-13T20:22:12Z
dc.date.issued2014
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/3031959/en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/3363
dc.description.abstractAntibody-mediated enhancement of Wesselsbron virus was investigated in P388D1 cell cultures. Virus infection was enhanced in culture by various dilutions of homologous and heterologous flavivirus antibody. Highest enhancement ratios and enhancing antibody titres were obtained with the homologous antibody. Enhancement of Wesselsbron virus infection in P388D1 cultures was also dependent on the multiplicity of infection (MOI) used; cultures infected at the lowest MOI produced the highest enhancement ratios. Of the four heterologous flavivirus IMAF tested for ability to enhance Wesselsbron virus infection, Potiskum virus antibody produced highest fold enhancement and possessed the highest enhancing antibody titre. Zika, Uganda S and Dakar bat IMAF produced lower fold enhancement and had lower enhancing antibody titres.en_US
dc.languageEnglishen_US
dc.subjectZika Research Projecten_US
dc.subjectZika Virusen_US
dc.subjectFlavivirusen_US
dc.titleAntibody-mediated enhancement of Wesselsbron virus in P388D1 cellsen_US
eihealth.countryOthersen_US
eihealth.categoryEpidemiology and epidemiological studiesen_US
eihealth.typeResearch protocol informationen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalAfrican Journal of Medicine and Medical Sciencesen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record